Cytokinetics to Present at the 24th Annual Needham Virtual Healthcare Conference

Cytkinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference

BENZINGA - Cytokinetics, a biopharmaceutical company focused on developing treatments for muscle-related diseases, announced that it will participate in the 24th Annual Needham Virtual Healthcare Conference.

The conference, which will take place on March 15-17, 2023, will feature presentations from leading biopharmaceutical companies, including Cytokinetics. The company's presentation will focus on its pipeline of innovative treatments for muscle-related diseases, including its lead candidate, tirasemtiv.

Tirasemtiv is a first-in-class, orally administered small molecule that targets the muscle-specific kinase (MuSK) protein. It has shown promise in improving muscle function and reducing muscle weakness in patients with muscle-related diseases. The company is currently conducting a Phase 3 clinical trial to evaluate the efficacy and safety of tirasemtiv in patients with amyotrophic lateral sclerosis (ALS).

Cytokinetics' participation in the Needham Virtual Healthcare Conference provides an opportunity for the company to share its latest research and development updates with the investment community and other stakeholders. The conference will also feature presentations from other leading biopharmaceutical companies, providing a comprehensive overview of the latest trends and advancements in the healthcare industry.

"We are excited to participate in the Needham Virtual Healthcare Conference and share our progress with the investment community," said Fady Malik, M.D., President and Chief Executive Officer of Cytokinetics. "Our pipeline of innovative treatments for muscle-related diseases is advancing rapidly, and we believe that tirasemtiv has the potential to make a significant impact on the lives of patients with ALS and other muscle-related diseases."

For more information about the Needham Virtual Healthcare Conference, please visit the conference website at www.needhamco.com. For more information about Cytokinetics and its pipeline of innovative treatments for muscle-related diseases, please visit the company's website at www.cytokinetics.com.